Internal Medicine, Interventional Cardiology · Oklahoma City, OK
NPI
1427045400
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4050 W Memorial Rd Fl 3
Oklahoma City, OK, 73120
Phone (405) 608-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$329K
4,341 services
Medicare patients, 2024
1,428
Average age 76
Drug cost, 2024
$1.1M
11,336 prescriptions
Company payments, 2025
$15K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas F McGarry was code 99214 (office e&m - established), 1,150 times for 712 patients. In total Thomas F McGarry billed 4,341 services in 60 codes, and Medicare paid $329K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,150 | 712 | $62.74 | $72K |
| 99214 Office E&M - Established | Office | 1,102 | 632 | $81.51 | $90K |
| 93306 Echocardiography (TTE/TEE) | Facility | 567 | 554 | $44.76 | $25K |
| 93306 Echocardiography (TTE/TEE) | Office | 501 | 494 | $82.68 | $41K |
| 99152 Anesthesia | Facility | 160 | 109 | $8.68 | $1,388 |
| 99215 Office E&M - Established | Facility | 133 | 120 | $99.21 | $13K |
| 99215 Office E&M - Established | Office | 79 | 70 | $120.37 | $9,509 |
| 93458 Percutaneous Transcatheterization | Facility | 75 | 72 | $193.08 | $14K |
| 99213 Office E&M - Established | Facility | 69 | 69 | $42.81 | $2,954 |
| 93248 Electrocardiogram | Facility | 50 | 49 | $17.86 | $893 |
| 92928 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 38 | 34 | $384.67 | $15K |
| 99205 Office E&M - New | Facility | 33 | 33 | $111.56 | $3,681 |
| 99205 Office E&M - New | Office | 33 | 33 | $150.29 | $4,959 |
| 99213 Office E&M - Established | Office | 29 | 29 | $56.72 | $1,645 |
| 93248 Electrocardiogram | Office | 28 | 28 | $17.21 | $482 |
By year: 2022 $369K for 4,169 services; 2023 $398K for 4,444 services; 2024 $329K for 4,341 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas F McGarry prescribed most often to Medicare patients was Metoprolol Succinate, with 2,199 prescriptions and refills. In total Thomas F McGarry wrote 11,336 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 2,199 | 5,423 | 585 | $37K |
| Atorvastatin Calcium Generic | 961 | 2,432 | 261 | $14K |
| Losartan Potassium Generic | 648 | 1,589 | 188 | $8,472 |
| Amlodipine Besylate Generic | 647 | 1,698 | 169 | $5,936 |
| Lisinopril Generic | 584 | 1,549 | 160 | $4,315 |
| Eliquis Apixaban | 536 | 836 | 105 | $473K |
| Clopidogrel Clopidogrel Bisulfate | 488 | 1,263 | 157 | $8,185 |
| Carvedilol Generic | 345 | 821 | 84 | $3,824 |
| Metoprolol Tartrate Generic | 333 | 929 | 102 | $2,918 |
| Spironolactone Generic | 286 | 687 | 84 | $3,405 |
| Furosemide Generic | 286 | 691 | 96 | $1,461 |
| Rosuvastatin Calcium Generic | 264 | 678 | 73 | $4,925 |
| Simvastatin Generic | 248 | 637 | 65 | $3,218 |
| Xarelto Rivaroxaban | 222 | 397 | 45 | $208K |
| Hydrochlorothiazide Generic | 215 | 559 | 63 | $776 |
Brand drugs: 1,107 claims; generic drugs: 10,229 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas F McGarry $15K ($15K in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.